GGrantIndex
← Leaderboards

Kurt R Zinn

University Of Alabama At Birmingham

$3,944,617
Attributed
$8,636,713
Total exposure
9
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$8,636,713 · 9

By mechanism

U01$3,854,000 · 1
R01$2,652,800 · 2
R21$1,137,884 · 2
P30$744,083 · 1
S10$152,439 · 1
P50$62,013 · 1

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImageAnimal ModelResearch PersonnelAnimalsPositron-Emission TomographyReceptorRadiotracerMolecular ImagingFluorescenceNovel TherapeuticsEvaluationGamma RaysImaging ModalityCancer TherapyMolecularTranslationsReportingClinical TrialsBlood VesselsPathway InteractionsLabelApoptosisBioimaging /Biomedical ImagingBase

Grant awards (36)

An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution$493,689
R01 · FY2024 · HL
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution$503,764
R01 · FY2023 · HL
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution$503,764
R01 · FY2022 · HL
Predicting glymphatic function via PET/MR imaging biomarkers and Nose to Brain contrast delivery$417,853
R21 · FY2022 · AG · contact PI
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution$481,146
R01 · FY2021 · HL
Molecular Imaging of Chemical Threats and Countermeasures$802,585
U01 · FY2019 · NS
Preclinical Imaging Shared Facility$189,493
P30 · FY2019 · CA · contact PI
Nonhuman Primate CNS Assessments of 18F-Insulin After IntranasalAdministration$125,813
R21 · FY2019 · AG · contact PI
Preclinical Imaging Shared Facility$8,695
P30 · FY2019 · CA · contact PI
Molecular Imaging of Chemical Threats and Countermeasures$804,973
U01 · FY2018 · NS
Nonhuman Primate CNS Assessments of 18F-Insulin After IntranasalAdministration$277,605
R21 · FY2018 · AG · contact PI
Preclinical Imaging Shared Facility$171,883
P30 · FY2018 · CA · contact PI
Preclinical Imaging Shared Facility$8,650
P30 · FY2018 · CA · contact PI
Preclinical Imaging Shared Facility$3,966
P30 · FY2018 · CA · contact PI
Preclinical Imaging Shared Facility$2,265
P30 · FY2018 · CA · contact PI
Preclinical Imaging Shared Facility$1,978
P30 · FY2018 · CA · contact PI
Molecular Imaging of Chemical Threats and Countermeasures$799,473
U01 · FY2017 · NS
Nonhuman Primate CNS Assessments of 18F-Insulin After Intranasal Administration$316,613
R21 · FY2017 · AG
Preclinical Imaging Shared Facility$191,405
P30 · FY2017 · CA · contact PI
Molecular Imaging of Chemical Threats and Countermeasures$717,099
U01 · FY2016 · NS
Preclinical Imaging Shared Facility$157,052
P30 · FY2016 · CA · contact PI
Lumina III System for UAB Optical Imaging$152,439
S10 · FY2016 · OD · contact PI
Preclinical Imaging Shared Facility$8,696
P30 · FY2016 · CA · contact PI
Molecular Imaging of Chemical Threats and Countermeasures$729,870
U01 · FY2015 · NS
PILOT PROJECT 3$33,494
U54 · FY2005 · CA
IN VIVO REPORTER SYSTEM FOR IMAGING GENE TRANSFER$229,368
R01 · FY2002 · CA
Core--In vivo imaging$0
P50 · FY2002 · CA
Core--In vivo imaging$0
P50 · FY2002 · CA
Core--In vivo imaging$0
P50 · FY2002 · CA
IN VIVO REPORTER SYSTEM FOR IMAGING GENE TRANSFER$222,973
R01 · FY2001 · CA
Core--In vivo imaging$0
P50 · FY2001 · CA
Core--In vivo imaging$0
P50 · FY2001 · CA
IN VIVO REPORTER SYSTEM FOR IMAGING GENE TRANSFER$218,096
R01 · FY2000 · CA
Core--In vivo imaging$20,671
P50 · FY2000 · CA
Core--In vivo imaging$20,671
P50 · FY2000 · CA
Core--In vivo imaging$20,671
P50 · FY2000 · CA